In summary, a hypothetical model of RBCK1 modulating the HIF1α signaling mechanism in ER+ breast cancer: RBCK1 can interact with the HIF1α protein to indirectly inhibit its polyubiquitination and degradation at K48 site, thereby promoting HIF1α target gene expression as well as breast cancer progression. Here, RBCK1 is linked to breast carcinoma.